Introduction tissue, the notochord and floor plate, are required for sclerotome formation (Rong et al., 1992; Brand-Saberi et The cell fate of skeletal muscle precursors is determined Pourquie et al., 1993; Fan and Tessier-Lavigne, cell-autonomously by the expression of "master genes" 1994; Goulding et al., 1994) . Lineage tracing studies encoding the MyoD family of myogenic regulatory fachave suggested the inheritance of cell fate plasticity in tors. The members of this family, myoD, myf5, myogenin, presomitic mesoderm and epithelial somites (Stern et and MRF4, encode muscle-specific transcriptional regal., 1988) . Somite rotation and grafting experiments also ulators that belong to the basic-helix-loop-helix (bHLH) demonstrate that cells at the newly formed epithelial class of DNA binding proteins (see reviews by Emerson, somite and presomitic mesoderm are not committed to 1990; Weintraub et al., 1991a) . All members of this family the dermomyotomal or sclerotomal lineage (Aoyama have the remarkable property of converting a variety of and Asamoto, 1988; Christ et al., 1992) . Signals from cells into myoblasts and myotubes (Weintraub et al., the surrounding tissue mediate a balance between the 1989). The members of the MyoD family share considerformation of sclerotome and dermomyotome in distinct able amino acid sequence similarity, particularly in the halves of the epithelial somite. The patterning of the 70 amino acid bHLH domain. Additional homology precise boundary between these two compartments in among these proteins is in a cysteine/histidine (C/H) rich immature somites and the maintenance of the scleroregion located immediately amino-terminal to the bHLH tome and dermomyotome identities throughout emdomain. The basic region is required for specific DNA bryogenesis are important steps for the proper formabinding, and the HLH region is required for dimerization tion of both tissues. . The function of the C/H region is not Myogenic cell fate is controlled by the MyoD family yet known. Myogenic factors heterodimerize with E12 of transcription factors, and the ectopic expression of or E47, which are alternative splicing products of the these factors can overcome many other preexisting cell fates in vitro and in vivo (Weintraub et al., 1989; Miner et al., 1992 and progeny of the myotome is essential for normal development. Similarly, the inhibition of expression/ Full-length I-mf cDNA clones were obtained by screening mouse embryonic libraries using the cDNA function of myogenic factors in the sclerotome, which is derived from the same precursors as the myotome, fragment isolated from the two-hybrid screen as probe (see Experimental Procedures). Three classes of clones, is an essential component of early development.
To understand how the activity of myogenic factors designated I-mfa, I-mfb and I-mfc, were obtained and subjected to further analysis. DNA sequencing and geis regulated during somitogenesis, we have used a yeast two-hybrid screen to isolate embryonic proteins that nomic mapping revealed that these three different transcripts are generated through differential poly(A) adespecifically interact with, and are involved in regulating the function of, MyoD. Below, we report the isolation nylation and alternative splicing (data not shown). Deduced polypeptide sequences suggest that the three and characterization of a novel myogenic repressor, I-mf (Inhibitor of MyoD family). We show that I-mf is highly I-mf proteins share a common amino-terminal region, but each has a different carboxyl terminus. The I-mfa expressed in the sclerotome, where MyoD expression is excluded. I-mf functions as a myogenic repressor that and I-mfb carboxyl termini are approximately equal in size and comprise one third of each polypeptide. The inhibits the transactivation activity of myogenic factors by retaining these factors in the cytoplasm and interferthird polypeptide, I-mfc, has a shorter unique carboxyl terminus ( Figure 1 ). GenBank Database searches of the ing with their binding to target DNA sequences. Our results suggest that I-mf may restrict the expression sequences of I-mf cDNAs and deduced I-mf proteins revealed no homology with any known cDNA or protein. of myogenic factors and maintain the identity of the sclerotome by preventing the function of myogenic facInterestingly, the sequences of all 15 clones isolated from a random primed two-hybrid library were overlaptors in the sclerotome.
ping, and all contained the unique carboxyl terminus of I-mfa (data not shown). This result suggests that the Results unique carboxyl terminus of I-mfa, which is characterized by its high content of cysteine residues, is involved Isolation of I-mf cDNA, which Encodes Three Novel Proteins in the interaction with MyoD. The onset of myoD gene expression occurs at about 10.5 days postcoitum. Therefore, to isolate proteins that potentially interact with and regulate MyoD function dur-I-mfa Specifically Interacts with MyoD Family Members In Vitro and In Vivo ing somitogenesis, we used a yeast two-hybrid screen with a library containing the VP16 activation domain
The yeast two-hybrid approach described above demonstrated interaction between a truncated I-mf protein fused to random-primed cDNA derived from mouse embryos 9.5 and 10.5 days postcoitum (Vojtek et al., 1993;  and a fragment of MyoD. A modified yeast one-hybrid system employing a b-galactosidase (b-gal) reporter . Amino acids 57 to 166 of MyoD, encompassing the most conserved C/H rich and bHLH was used to determine if full length I-mf and MyoD interact. Full-length MyoD with its own transactivation dodomains, were fused to the LexA DNA binding domain and used as a "bait" (LexAMyoD57-166). From approximain was cotransformed with constructs containing the LexA DNA binding domain fused to full length I-mfa, -b, mately 8 3 10 6 clones screened, 550 clones were selected that showed specific interaction with the MyoD or -c (LexA-I-mfa, LexA-I-mfb, LexA-I-mfc, respectively) into yeast strain L40. b-gal activities were deterbait. From this collection, about 130 clones were identified as cDNA fragments encoding members of the E mined quantitatively in L40 yeast cells expressing different combinations of these proteins. As shown in Table  protein family and 100 clones encoding Id family members (see Experimental Procedures), both of which are 1, L40 expressing LexA, LexA-I-mfa, LexA-I-mfb, or LexA-I-mfc exhibited background levels of b-gal activiknown HLH partners of MyoD. From the remaining clones, one gene called I-mf, which represented 15 indeties ranging from 0.1 to 0.9 (arbitrary units). However, b-gal activity was 5-fold higher than the LexA-I-mfa pendent VP16 fusions of 18 clones, was identified and characterized further.
control in the same yeast strain bearing LexA-I-mfa and To investigate the possible function of I-mf in embryonic myogenesis, we first analyzed the expression pattern I-mfa but not with I-mfb or I-mfc.
Since the MyoD sequence used in the original isolation of I-mfa during mouse embryogenesis. Parasagittal sections of mouse embryos at E11.5 were examined by in of I-mf is conserved among myogenic factors, we determined whether interaction between I-mf and other MyoD situ hybridization using a digoxygenin labeled antisense riboprobe corresponding to the 39 region of the mouse family members is detectable in this one-hybrid system. Interestingly, in yeast expressing LexA-I-mfa and full-I-mfa sequence that encodes its unique carboxyl terminus. As a comparison, sections adjacent to those examlength Myf5 or myogenin, b-gal activity was about 70-to 80-fold higher than in those expressing LexA-I-mfa ined for I-mfa expression were hybridized with a MyoD alone. Consistent with the MyoD result, the interaction with Myf5 or Myogenin was also specific to I-mfa (Table  1 ). In contrast, no stimulation of the b-gal reporter was observed in L40 expressing LexA-I-mf and full-length E12 or Lethal of Scute (AS-C T3), two other bHLH transcriptional activators (Table 1) . Our failure to detect significant interaction between LexA-I-mfa and E12 or T3 suggests that I-mfa may interact specifically with the myogenic family of bHLH proteins.
Physical association of I-mf and myogenic factors was also demonstrated in an in vitro coprecipitation assay. Figure 2A shows that 35 S-labeled in vitro translated Myf5, MyoD, and Myogenin are coprecipitated by a bacterially expressed fusion protein containing the maltose binding protein (MBP) and I-mfa (lane 2-4). In contrast, these myogenic factors are not coprecipitated in the presence of MBP-I-mfc ( Figure 2A , lane 1; data not shown). No significant association between E protein and I-mfa is detectable in this assay (lane 5 of Figure 2A ), further suggesting that I-mfa may interact specifically with In situ hybridization with digoxygenin-labeled antisense riboprobes derived from I-mfa (A) and MyoD (B) cDNA or with 35 S-labeled antisense riboprobes derived from I-mfa (C) and Myf5 (D) cDNA were performed on adjacent parasagittal sections (A and B) of E11.5 mouse embryos or adjacent transverse sections of the caudal region of E11.5 mouse embryos. D, dermomyotome; DA, dorsal aorta; DG, dorsal root ganglion; H, heart; L, liver; N, neural tube; Sc, sclerotome; St, stomach.
antisense riboprobe. As shown in Figure 3A , I-mfa tran-I-mfa Inhibits the MyoD Family-Dependent Transcriptional Activation scripts are highly expressed in the sclerotome. However, the expression of MyoD is concentrated in the myotome
The transcripts of I-mfa, a MyoD-interaction protein, and the members of MyoD family accumulate in a mutually ( Figure 3B ). The transverse sections of caudal somites of the same stage embyos show high level of I-mfa exclusive fashion in differentiating somites, suggesting that I-mfa may play an important role in regulating the expression in the sclerotome, the ventral subdomain of the somites ( Figure 3C ), while Myf5 is detected excluexpression/function of the MyoD family. To determine if I-mfa influences the activity of myogenic factors, the sively in the myotome part of dermomyotome, the dorsal subdomain of somites ( Figure 3D ). A similar expression ability of MyoD family members to transactivate an E box-driven reporter construct was assayed in the prespattern of I-mfa was also observed in newly formed somites of E8.5 mouse embryos (N. Kraut, unpublished ence or absence of I-mf. NIH3T3 cells were transiently transfected with myogenic regulatory factors, I-mf, and data). These results demonstrate a mutually exclusive pattern of high level expression of I-mfa and the MyoD a chloramphenicol acetyltransferase (CAT) reporter gene controlled by four copies of the E box sequences family members in mouse somites.
In addition to its expression in somites, I-mfa is also (p4RCAT). I-mfa reduced the transactivation activity of all three myogenic factors tested to 10%-23% of the expressed in the notochord and at lower levels in the neural tube ( Figure 3C ) as well as in limb buds, heart, control level (Table 2 ). In contrast, I-mfb and -c showed no significant effect on the myogenic factor-dependent branchial arches, head mesenchyme, and various other parts of the mouse embryo (data not shown). Moreover, reporter activation. Moreover, I-mfa did not significantly inhibit the transactivation activity of E12, constructed analysis of RNA from various mouse tissues reveals that I-mfa is most highly expressed in skeletal tissue, but is in the same expression vector as MyoD family members, when assayed on the same reporter construct (Table  expressed at lower levels in almost every other tissue analyzed (data not shown).
2). This result demonstrates that I-mfa is not a general The CAT activities were determined in NIH3T3 cells transiently transfected with the p4RCAT reporter together with combinations of expression vectors as indicated. The CAT activity from each cotransfection of myogenic factors and I-mf was normalized to the value from each cotransfection with empty vector to allow a direct comparison of the I-mf effect on each myogenic factor. The data represent the average of relative values from 4 to 6 experiments for MyoD, Myf5, and Myogenin; 3 to 4 experiments for E12.
repressor of bHLH transcriptional activators, and is condifferentiated into elongated myotubes ( Figures 4A-4C and 4G-4L). However, consistent with the repressor acsistent with the possibility that the repression activity of I-mfa may be specific to MyoD family members. We tivity of I-mfa, cells expressing both I-mfa and Myf5 demonstrated repression of muscle differentiation; have also observed that the I-mfa repression of myogenic regulatory factor activity occurs (i) in a dosez80% of the Myf5-expressing cells showed no MyHC expression and retained their fibroblast morphology dependent manner, (ii) in C3H10T1/2 cells cultured in either growth medium or differentiation medium, and (iii) ( Figures 4D-4F ). Our results suggest that I-mfa can inhibit MyoD family-mediated muscle differentiation in tiswhen assayed on a CAT reporter driven by 3.3 kb of the muscle-specific MCK promoter (data not shown).
sue culture cells. Together, these results suggest that I-mfa represses the transactivation activity of the MyoD family independent I-mfa Retains MyoD Family Members in the Cytoplasm by Masking Their Nuclear of cell type, culture conditions and reporter constructs used.
Localization Signals
The previous results suggest that I-mfa suppresses Myf5-mediated myogenesis by inhibiting the transacti-I-mfa Inhibits Myf5-Mediated Muscle Differentiation Having shown that I-mfa modulates the transactivation vation activity of these factors. A potential mechanism of this inhibition is suggested by the alteration in the activities of myogenic factors, we next asked if I-mf can inhibit MyoD family-dependent myogenesis. I-mfa and subcellular localization of Myf5 when coexpressed with I-mfa: in the presence of I-mfa, Myf5 remains predomiMyf5 were coexpressed transiently in NIH3T3 fibroblasts, and muscle differentiation was assayed by the nantly in the cytoplasm (see Figure 4D ). To determine if the cytoplasm-expressed Myf5 is colocalized with I-mfa, appearance of the specific muscle marker myosin heavy chain (MyHC), as well as by cellular morphology. When NIH3T3 cells were transfected with expression constructs encoding Myf5 and HA epitope-tagged I-mf. Indicotransfected with Myf5 and different control vectors, z80% of the Myf5 positive cells expressed MyHC and rect immunofluorescence staining was performed using Myf5 and anti-HA antibodies. Figure 5 shows that I-mfa NLSMyf5 and I-mfa. Thus, the rescue of nuclear localization of Myf5 by the SV40 NLS suggests that I-mfa seprotein is distributed primarily throughout the cytoquesters myogenic regulatory factors in the cytoplasm plasm, although weak staining is detectable in the nuthrough direct protein interaction which masks the NLS cleus. This subcellular localization does not change in of these factors. the presence of Myf5 ( Figures 5B, 5E , and 5H). In the absence (data not shown) or in the presence of I-mfb or I-mfc ( Figures 5D and 5G ), Myf5 is localized exclu-I-mfa Interferes with the DNA Binding Activity sively in the nucleus. In contrast, when coexpressed of the MyoD Family Members with I-mfa, Myf5 protein colocalizes with I-mfa in the As shown above, the nuclear localization of Myf5 can cytoplasm ( Figures 5A-5C ). Similar analyses with other be rescued by addition of the SV40 NLS. To determine myogenic factors revealed that I-mfa retains Myogenin if the rescue of nuclear localization is sufficient to restore equally well in the cytoplasm, but it retains MyoD to Myf5-mediated myogenesis in the presence of I-mfa, a lesser degree (data not shown). The I-mfa-mediated we examined the expression of MyHC in NIH3T3 cells cytoplasmic retention may be specific to myogenic factransiently transfected with NLSMyf5 and HA-tagged tors, since the nuclear localization of E protein remained I-mf expression vectors. NLSMyf5 alone induced MyHC unchanged when coexpressed with I-mfa (data not expression in transfected NIH3T3 cells to a similar extent shown). These results suggest a correlation among the as wild-type Myf5 ( Figures 6A-6C ). In contrast, when binding, repression, and cytoplasmic retention of the coexpressed with I-mfa, most NLSMyf5-expressing MyoD family by I-mfa. cells did not express detectable MyHC protein (Figures MyoD has two nuclear localization signals (NLS), one 6D-6F), similar to what has been observed with Myf5 in the basic region and one in the helix 1 domain ( Van- in the presence of I-mfa. This result suggests that the dromme et al., 1995). The location of these NLS overlaps nuclear NLSMyf5 is functionally impaired in the preswith the I-mf interaction region, raising the possibility ence of I-mfa. In a parallel experiment, we found that that I-mfa may simply mask the NLS of the MyoD family the transactivation activity of NLSMyf5 was also remembers, resulting in their cytoplasmic retention. If this pressed by I-mfa (data not shown). These results imply masking hypothesis were correct, adding a presumably that the sequestration of myogenic regulatory factors in unmasked NLS outside of the C/H rich and bHLH regions the cytoplasm is not the sole mechanism by which I-mfa of myogenic regulatory factors should restore their nuinhibits the activities of the MyoD family members. clear localization. To test this hypothesis, one SV40 T The I-mfa interacting region of myogenic regulatory antigen NLS was added to the amino terminus of Myf5 factors also overlaps with the DNA binding and dimeriza-(NLSMyf5). When coexpressed with I-mfa in NIH3T3 tion domains of these proteins. Thus, gel shift assays cells, NLSMyf5 localized exclusively in the nucleus (Fig- with an E box containing probe (B1/B2) were performed ures 5J-5L). A similar "nuclear rescue" was observed to determine whether I-mfa interferes with the DNA bindfor NLSMyogenin and NLSMyoD (data not shown). Since ing and/or dimerization of myogenic factors. As shown I-mfa associates equally well with NLSMyf5 and Myf5 in Figure 7 , homodimers of in vitro translated Myogenin in both coprecipitation (data not shown) and gel shift bound the B1/B2 probe and formed a low mobility comassays (see Figure 7B) , it is unlikely that the nuclear plex ( Figure 7A, lane 2) . A fusion protein (MBP-I-mfaDN) containing the unique I-mfa domain from amino acid 163 rescue is due to a failure in association between to 246, which is sufficient for interaction with myogenic activity of E47 was not affected by I-mfaDN even when present in a 192-fold molar excess ( Figure 7A , lane 11-factors (Chen, 1996) , competed with this complex formation in a dose-dependent manner ( Figure 7A , lanes 14), suggesting that I-mfa may interfere specifically with DNA binding of myogenic factors. Figure 7B shows that 3-8). Interference of 50% was observed when MBP-ImfaDN was present in 3-to 5-fold molar excess. As a MBP-I-mfaDN also interferes with the DNA binding activities of E12/Myogenin, E12/MyoD, E12/Myf5, and E12/ control, the MBP fusion proteins containing either the unique carboxyl domain of I-mfb (amino acid 164 to 251) NLSMyf5 heterodimers. However, up to 60-to 120-fold molar excess of MBP-ImfaDN is required for 50% inhibior full-length I-mfc showed no effect on Myogenin DNA binding, even when present in 48-fold molar excess (Fig- tion of the DNA binding activity of these heterodimers. These results suggest that I-mfa can inhibit the function ure 7A, lane 9 and 10). In addition, the DNA binding 2-4) or from a 160-to 640-fold molar excess relative to MyoD, Myf5, and NLSMyf5 (lane 6-8, 10-12, and 14-16, respectively). Gel electrophoresis was conducted after addition of the labeled B1/B2 probe. Asterisk indicates the heterodimer complex.
of myogenic factors by interfering with their binding to with MyoD than with other myogenic regulatory factors in mouse embryos. I-mfa also had slightly weaker effects DNA target sites. This interference could be mediated through an inhibition of dimerization by binding to monoon MyoD than on the other myogenic factors tested in both transactivation repression and cytoplasmic retenmers of the MyoD family members (see Discussion) or through an effect on DNA binding per se.
tion assays.
Discussion The Function of I-mfa in Myogenesis
Early in development, I-mfa, a repressor of myogenesis, We have isolated a novel sclerotome-expressed myois highly expressed in the sclerotomal domain of sogenic repressor, I-mfa, which interacts with members mites. In contrast, myogenic factors are detected in the of the MyoD family. I-mfa represses both transcriptional dermomyotomal domain of somites. This mutually exactivation and myogenesis mediated by the MyoD famclusive pattern of high level expression in developing ily. These repressor activities of I-mfa appear to be due somites suggests a model for the function of I-mfa durto its ability to mask the NLS of myogenic regulatory ing myogenesis: in response to signals from the notofactors, thereby causing the cytoplasmic retention of the chord or neural tube, the expression of I-mfa is elevated MyoD family, and/or its interference with MyoD family in the sclerotomal precursors, thereby inhibiting the members binding to DNA.
transactivation activities of Myf5 and MyoD and their auto-regulation and cross-regulation loops in the sclerotome, but not in the dermomyotome.
Three Transcripts Are Encoded
Sclerotomal and dermomyotomal cells are derived by the I-mf Gene from the same precursors in immature somites. In At least three polypeptides are encoded by the I-mf mouse embryos, low levels of Myf5 transcripts are degene during mouse embryogenesis. Each contains a tectable in the immature somites (Ott et al. 1991) , as common amino-terminal region and a diverse carboxywell as in unsegmented presomitic mesoderm (Kopan terminal region. I-mfa interacts with MyoD family memet al., 1994) . Myf5 protein is detected in occasional sclerbers and functions as a myogenic repressor. In contrast, otomal cells (Smith et al., 1994) , further supporting the I-mfb and I-mfc do not interact with the MyoD family in notion that myogenic repressors are required in the any of the systems used in our analyses. The sequence sclerotome to restrain the high level expression of myodiversity among these three I-mf transcripts clearly suggenic factors. The finding of rib defects in Myf5, Myogests that the unique carboxy-terminal region of I-mfa genin, or MRF4 homozygous mutant mice (Olson et al. , is the domain required for the interaction with MyoD 1996, and references therein) also suggests a possible family members and myogenic repression.
interplay between dermomyotome and sclerotome deWhile our results suggest that I-mfa may function as rivatives. The presence of I-mfa in the sclerotome proa myogenic repressor, the functions of I-mfb and I-mfc vides a potential regulatory mechanism for the control are unknown. I-mfb contains a unique 90 amino acid of cell fate determination in both dermomyotome and carboxyl terminus, which is about the same size as the sclerotome: in the early stage of somite differentiation, unique carboxyl terminus of I-mfa. Since the carboxyl I-mf may specify the dorsal-ventral pattern by negatively terminus of I-mfa is the region responsible for interacting regulating myogenic factors in the ventral part of sowith the MyoD family, we speculate that the correspondmites. In the later stage, I-mfa may also maintain the ing region of I-mfb might interact with as yet unidentified identity of sclerotomal cells by preventing the sclerotargets. In contrast to I-mfa and I-mfb, I-mfc contains tome cells from switching their cell fate into myoblasts. a relatively short 28-residue unique carboxyl terminus, However, we can not rule out the possibility that I-mfa which may also provide interaction specificity with its may be directly involved in the formation or development own targets. Clearly, the idea of specific targets for each of the sclerotome, possibly by affecting the activity of polypeptide encoded by the I-mf gene requires further scleraxis, a sclerotomal expressed bHLH (Cserjesi et al., investigation. 1995) or other yet to be identified bHLH proteins in the sclerotome.
I-mfa Interacts with Members of the MyoD Family
Yeast one-hybrid and both in vitro and in vivo coprecipitation assays demonstrate that I-mfa associates with
The Mechanism of I-mfa-Mediated Myogenic Repression members of the MyoD family. The well-defined HLH dimerization domain of MyoD is required for interaction I-mfa is one of the few known direct inhibitors of myogenic bHLH factor function. Id inhibits myogenesis dibetween bHLH proteins; however, it is not sufficient for interacting with I-mfa. The Helix 2 domain of MyoD is rectly by forming nonfunctional heterodimers with myogenic factors and indirectly by titrating out E12 or E47 also dispensable for this interaction (Chen, 1996) , suggesting that the interaction property of MyoD/I-mfa is (Jen et al., 1992) . Mtwist inhibits myogenesis by preventing trans-activation of muscle target genes by the different from that of bHLH dimerization.
In the yeast assay system, I-mfa interacts with MyoD MEF2 family of myogenic regulatory factors and by titrating E proteins away from myogenic bHLH factors (Spicer more weakly than with Myf5 or Myogenin (Table 1) ; analysis of various MyoD-deletion constructs suggests this et al., 1996) . Our results show that I-mfa can only weakly interfere weak interaction between MyoD and I-mfa is likely due to interference from the amino terminus of MyoD (Table  with DNA binding of MyoD/E12 ( Figure 7B ), suggesting that I-mfa might recognize monomers of MyoD family 1). However, it is unclear if I-mfa associates more weakly serve as a color indicator when screening for the yeast transmembers. This possibility is supported by the findings formants that lose bait constructs. The two-hybrid screen was perthat the trans-activation activity of MyoD/E47 forcedformed as described previously (Vojtek et al., 1993; dimers (Neuhold and Wold, 1993 ) is resistent to I-mfa; al., 1995) three genes are expressed in the sclerotome but not in the myotome. Futhermore, their expression outside of
Plasmid Constructs
The deduced protein coding regions of I-mfa, -b, and -c were PCR somites also shows considerable overlap, suggestive amplified and subcloned into the EcoRI-XhoI sites of the mammalian of possible regulatory interactions.
expression vector pCS2 Turner and Weintraub, Our results suggest that I-mfa represses the function Baeuerle, 1990) . However, the extent of molecular simiexpression vector pEMBLye30/2 (Banroques et al., 1986) . The same PCR products of Myf5 and Myogenin were also subcloned into larity that may exist between these two systems requires mammalian expression vector pEMScribe (Davis et al., 1987) or further investigation.
pCS2NLS to make pEMSVMyf5 and pEMSVMyo-A "cytoplasmic anchor" of MyoD, which would funcgenin or pCSNLSMyf5 and pCSNLSMyogenin, respectively. tion similarly to I-mfa, has been proposed to be an important regulator of cell fate in Xenopus embryos (Rupp Yeast Quantitative b-Galactosidase Activity Assays et al., 1994) . The transcriptional activation of Xenopus S. cerevisiae strain L40 was transformed by the standard lithium MyoD (XMyoD) occurs at a low level throughout the acetate method and transformant colonies were used for b-galactosidase assays as described (Trawick et al., 1989) . The b-galacembryo at and shortly after the midblastula transition tosidase units were calculated using the formula: (OD 420 3 1000)/ (MBT). However, XMyoD accumulates to a high level (OD 600 3 reaction time in minutes).
only in the presumptive mesoderm (Harvey, 1991; Rupp and Weintraub 1991) . The XMyoD protein, which is also
In Vitro and In Vivo Coprecipitation Assays expressed ubiquitously around MBT, appears to be lo-MBP-I-mf fusion proteins were purified using a bacterial expression calized in nuclei in the presumptive mesoderm. In the system as described (Vojtek et al., 1993) . bHLH proteins were synthesized in vitro using a TNT-coupled reticulocyte system and laectoderm, XMyoD is retained in the cytoplasm through buffered saline (PBS) and incubated for 1 hr at room temperature. Twenty-five microliters of a 50% suspension of amylose resin (New England Biolabs) and 1 ml of washing buffer containing 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM MgCl 2, 0.1% NP-40 (TNM Experimental Procedures buffer) were then added, followed by 30 min incubation at room temperature. The bound protein complex and resin were washed Yeast Two-Hybrid Screening and Mouse Library Screening pLexAMyoD57-166, MyoD bait, was constructed by PCR amplificafive times with TNM buffer. Prior to analysis on SDS-polyacrylamide gel and detection by autoradiography, the bound proteins were tion of the MyoD insert from pEMSVMyoDDNDC and cloned in-frame into the pBTM116 vector. The Ade2 eluted from the resin with 20 mM maltose in PBS. For in vivo association assays, NIH3T3 cells were transfected gene, isolated as a BamHI fragment from pL909 plasmid (a gift from R. Keil), was cloned into the PvuII site of the MyoD bait plasmid to with expression vectors encoding MyoD and HA tagged I-mf. Cell
